Accelerate Diagnostics Gross Profit 2010-2024 | AXDXQ
Accelerate Diagnostics gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Accelerate Diagnostics Annual Gross Profit
(Millions of US $) |
| 2024 |
$3 |
| 2023 |
$3 |
| 2022 |
$3 |
| 2021 |
$0 |
| 2020 |
$4 |
| 2019 |
$4 |
| 2018 |
$2 |
| 2017 |
$3 |
| 2016 |
$0 |
| 2015 |
$0 |
| 2014 |
$0 |
| 2013 |
$0 |
| 2012 |
$0 |
| 2012 |
$0 |
| 2011 |
$1 |
| 2010 |
$2 |
| 2009 |
$1 |
Accelerate Diagnostics Quarterly Gross Profit
(Millions of US $) |
| 2024-12-31 |
$0 |
| 2024-09-30 |
$1 |
| 2024-06-30 |
$1 |
| 2024-03-31 |
$1 |
| 2023-12-31 |
$1 |
| 2023-09-30 |
$0 |
| 2023-06-30 |
$1 |
| 2023-03-31 |
$1 |
| 2022-12-31 |
$1 |
| 2022-09-30 |
$1 |
| 2022-06-30 |
$1 |
| 2022-03-31 |
$1 |
| 2021-12-31 |
$-3 |
| 2021-09-30 |
$1 |
| 2021-06-30 |
$1 |
| 2021-03-31 |
$1 |
| 2020-12-31 |
$1 |
| 2020-09-30 |
$1 |
| 2020-06-30 |
$1 |
| 2020-03-31 |
$1 |
| 2019-12-31 |
$2 |
| 2019-09-30 |
$1 |
| 2019-06-30 |
$1 |
| 2019-03-31 |
$1 |
| 2018-12-31 |
$1 |
| 2018-09-30 |
$1 |
| 2018-06-30 |
$1 |
| 2018-03-31 |
$0 |
| 2017-12-31 |
$1 |
| 2017-09-30 |
$1 |
| 2017-06-30 |
$1 |
| 2017-03-31 |
$1 |
| 2016-12-31 |
$0 |
| 2016-09-30 |
$0 |
| 2016-06-30 |
$0 |
| 2016-03-31 |
$0 |
| 2015-12-31 |
$0 |
| 2015-09-30 |
$0 |
| 2015-06-30 |
$0 |
| 2015-03-31 |
$0 |
| 2014-12-31 |
$0 |
| 2014-09-30 |
$0 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$0 |
| 2013-09-30 |
$0 |
| 2013-06-30 |
$0 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
|
| 2012-10-31 |
$0 |
| 2012-09-30 |
$0 |
| 2012-07-31 |
|
| 2012-06-30 |
$0 |
| 2012-04-30 |
$0 |
| 2012-03-31 |
$0 |
| 2012-01-31 |
$0 |
| 2011-10-31 |
$0 |
| 2011-07-31 |
|
| 2011-04-30 |
$0 |
| 2011-01-31 |
$0 |
| 2010-10-31 |
$0 |
| 2010-07-31 |
|
| 2010-04-30 |
$0 |
| 2010-01-31 |
$0 |
| 2009-10-31 |
$0 |
| 2009-07-31 |
|
| 2009-04-30 |
$0 |
| 2009-01-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED INSTRUMENTS |
$0.001B |
$0.012B |
|
Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.
|
